Antioxidant properties of clozapine and related neuroleptics

References

• Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. Clarendon Press, Oxford 1989
   Google Scholar
• Halliwell B., Gutteridge J.M.C. Oxygen radicals and the nervous system. Trends in Neurosciences 1985; 8: 22–26
   Web of Science ®Google Scholar
• Simonian N.A., Coyle J.T. Oxidative stress in neurodegenerative diseases. Annual Review Pharmacology and Toxicology 1996; 36: 83–106
   PubMed Web of Science ®Google Scholar
• Dexter D.T., Carter C.J., Wells F.R., Javoid-Agid F., Agid Y., Lees A., Jenner P., Marsden C.D. Basal lipid peroxidation in the substantia nigra is increased in Parkinson's disease. Journal of Neurochemistry 1989; 52: 381–389
   PubMed Web of Science ®Google Scholar
• Hirsch E.C., Brandel J.P., Galle P., Javoy-Agid F., Agid Y. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. Journal of Neurochemistry 1991; 56: 444–451
   Google Scholar
• Swaiman K.F., Smith S.A., Trock G.L., Siddiqui A.R. Sea-blue histiocytes, lymphocytic cytosomes and 59Fe-studies in Hallervorden-Spatz syndrome. Neurology 1983; 33: 301–305
   PubMedGoogle Scholar
• Perry T.L., Norman M.G., Yong V.W., Crichton J.U., Hansen S., Kish S.J. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Annals of Neurology 1985; 18: 482–489
   PubMedGoogle Scholar
• Jesberger J.A., Richardson J.S. Oxygen free radicals and brain dysfunction. International Journal of Neurosciences 1991; 57: 1–17
   PubMed Web of Science ®Google Scholar
• Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689–695
   PubMed Web of Science ®Google Scholar
• Bindoli A., Rigobello M.P., Deeble D.J. Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radical Biology and Medicine 1992; 13: 391–405
   PubMed Web of Science ®Google Scholar
• Dalla Libera A., Rigobello M.P., Bindoli A. Inhibitory action of neuroleptic drugs and serotonin on dopamine autoxidation and lipid peroxidation. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1995; 19: 291–298
   Google Scholar
• Miyamoto M., Murphy T.H., Schnaar R.L., Coyle J.T. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. The Journal of Pharmacology and Experimental Therapeutics 1989; 250: 1132–1140
   PubMed Web of Science ®Google Scholar
• Puttfarcken P.S., Getz R.L., Coyle J.T. Kainic acid-induced lipid peroxidation: protection with butylated hydroxytoluene and U7851F in primary cultures of cerebellar granule cells. Brain Research 1993; 624: 223–232
   PubMedGoogle Scholar
• Lieberman J.A., Johns C.A., Kane J.M., Rai K., Pisciotta A.V., Saltz B.L., Howard A. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs. Journal of Clinical Psychiatry 1988; 49: 271–277
   PubMed Web of Science ®Google Scholar
• Fischer V., Haar J.A., Greiner L., Lloyd R.V., Mason R.P. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis. Molecular Pharmacology 1991; 40: 846–853
   PubMed Web of Science ®Google Scholar
• Friend J., Mayer A.M. The enzymic destruction of carotenoids by isolated chloroplasts. Biochimica et Biophysica Acta 1960; 41: 422–429
   PubMed Web of Science ®Google Scholar
• Bors W., Michel C., Saran M. Inhibition of the bleaching of the carotenoid crocin. A rapid test for quantifying antioxidant activity. Biochimica et Biophysica Acta 1984; 796: 312–319
   Web of Science ®Google Scholar
• van Amsterdam F.T.M., Roveri A., Maiorino M., Ratti E., Ursini F. Lacidipine: a dihydropyridine calcium antagonist with antioxidant activity. Free Radical Biology and Medicine 1992; 12: 183–187
   PubMed Web of Science ®Google Scholar
• Tubaro F., Micossi E., Ursini F. The antioxidant capacity of complex mixtures by kinetic analysis of crocin bleaching inhibition. Journal of American Oil Chemists Society 1996; 73: 173–179
   Web of Science ®Google Scholar
• Ernster L., Nordenbrand K. Microsomal lipid peroxidation. Methods in Enzymology 1967; 10: 574–580
   Google Scholar
• Buege J.D., Aust S.D. Microsomal lipid peroxidation. Methods in Enzymology 1978; 52: 302–310
   PubMedGoogle Scholar
• Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 1990; 186: 464–478
   PubMed Web of Science ®Google Scholar
• Gornall A.G., Bardawill C.J., David M.M. Determination of serum proteins by means of the biuret reaction. The Journal of Biological Chemistry 1949; 177: 751–766
   PubMed Web of Science ®Google Scholar
• Lin G., McKay G., Hubbard J.W., Midha K.K. Decomposition of clozapine N-oxide in the qualitative and quantitative analysis of clozapine and its metabolites. Journal of Pharmaceutical Sciences 1994; 83: 1412–1417
   PubMedGoogle Scholar
• Jeding I., Evans P.J., Akanmu D., Dexter D., Spencer J.D., Aruoma O.I., Jenner P., Halliwell B. Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs. Biochemical Pharmacology 1995; 49: 359–365
   PubMed Web of Science ®Google Scholar
• Janero D.R., Burghardt B. Prevention of oxidative injury to cardiac phospholipid by membraneactive “stabilizing agents”. Research Communications in Chemical Pathology and Pharmacology 1989; 63: 163–173
   PubMedGoogle Scholar
• Hara S., Endo T., Kuriiwa F., Kano S., Iwata N. Antioxidant effect of calmodulin antagonists in rat brain homogenate. Research Communications in Chemical Pathology and Pharmacology 1992; 76: 367–370
   PubMedGoogle Scholar
• Roy D., Pathak D.N., Singh R. Effect of chlorpromazine on the activities of antioxidant enzymes and lipid peroxidation in the various regions of aging rat brain. Journal of Neurochemistry 1984; 42: 628–633
   PubMed Web of Science ®Google Scholar
• Kagan V.E., Prilipko L.L., Savov V.M. Formation of inhibitors of lipid peroxidation during oxidative metabolism of hydrophobic xenobiotics catalyzed by mixed function oxygenases. Acta Physiologica et Pharmacologica Bulgarica 1984; 10: 46–56
   PubMedGoogle Scholar
• Marshall K.A., Reiter R.J., Poeggeler B., Aruoma O.I., Halliwell B. Evaluation of the antioxidant activity of melatonin in vitro. Free Radical Biology and Medicine 1996; 21: 307–315
   PubMed Web of Science ®Google Scholar
• Smith C.D., Carney J.M., Starke-Reed P.F., Oliver C.N., Stadtman E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal, aging and in Alzheimer disease. Proceedings of the National Academy of Sciences USA 1991; 88: 10540–10543
   PubMed Web of Science ®Google Scholar
• Elkashef A.M., Ruskin P.E., Bacher N., Barret D. Vitamin E and the treatment of tardive dyskinesia. American Journal of Psychiatry 1990; 147: 505–506
   PubMed Web of Science ®Google Scholar
• Dabiri J.M., Pasta D., Darby J.K., Mosbacher D. Effectiveness of vitamin E for treatment of tardive dyskinesia. American Journal of Psychiatry 1994; 15: 925–926
   Google Scholar
• Poewe W., Granata R. Pharmacological treatment of Parkinson's disease. Movement Disorders, Neurologic Principles and Practice, R.L. Watts, W.C. Koller. McGraw-Hill, New York 1997; 201–219, In
   Google Scholar
• Piette L.H., Bulow G., Yamazaki I. Electron paramagnetic resonance studies of the chlorpromazine free radical formed during enzymatic oxidation by peroxidase-hydrogen peroxide. Biochimica et Biophysica Acta 1964; 88: 120–129
   PubMedGoogle Scholar
• Valoti M., Sipe H.J., Jr., Sgaragli G., Mason R.P. Free radical intermediates during peroxidase oxidation of 2-t-butyl-4-methoxyphenol, 2,6-di-t-butyl-4-methylphenol, and related phenol compounds. Archives of Biochemistry and Biophysics 1989; 269: 423–432
   PubMed Web of Science ®Google Scholar